New Therapeutics for Traumatic Brain Injury

Treatment of Mood Disorders Following Traumatic Brain Injury

Introduction Mood disorders are a common development in cases of traumatic brain injury (TBI). A number of factors contribute to the outcome of this phenomenon. For instance, factors preceding the trauma (eg, personal medical history, genetic vulnerability), characteristics of the…

Docosahexaenoic Acid and Omega 3 Fatty Acids

Docosahexaenoic Acid and Omega 3 Fatty Acids Administration of omega 3 polyunsaturated fatty acids (n-3 PUFAs) is a biologically plausible, yet clinically untested, candidate therapeutic strategy to prevent or blunt neurologic disability after traumatic brain injury (TBI). The biologic plausibility…

Ceftriaxone Treatment of TBI

Traumatic Brain Injury and Glutamate Excitotoxicity Traumatic brain injury (TBI) is among the most common causes of morbidity and mortality in the USA across all age groups ( ). Beyond the mechanical injury, TBI triggers a cascade of biochemical events…